Unlocking advanced heart health insights for everyone
CONNEQT Pulse goes beyond blood pressure, putting clinical-grade arterial health insights in your hands
Powered by Pulse Wave Analysis (PWA), CONNEQT Pulse deciphers the hidden signals in each heartbeat to generate vascular biomarkers that go beyond traditional blood pressure, making clinical-grade arterial health insights accessible for everyday use.
Not all blood pressure readings are created equally
Traditional blood pressure cuffs give you a single pressure reading, but they miss the full picture of how your arteries are functioning. CONNEQT Pulse goes deeper by analyzing arterial waveforms to assess your vascular health in real-time.
How flexible or stiff your arteries are
(a key factor in cardiovascular risk)
How well your arteries respond to each heartbeat
(vascular compliance)
Early warning signs of hypertension, arterial aging, and cardiovascular disease
By understanding these patterns, you gain a proactive edge in optimizing your heart health.
Research-Backed Health Insights
Traditional blood pressure readings only tell part of the story. The Pulse arterial health monitor uses Pulse Wave Analysis (PWA) to measure key vascular biomarkers that predict cardiovascular (CV) risk before symptoms appear.
Results & Clinical Interpretation of CONNEQT Arterial Health Biomarkers
Measurement | Central Blood Pressure | Central Pulse Pressure | Pulse Pressure Amplification | Augmentation Pressure | Augmentation Index |
---|---|---|---|---|---|
Threshold | >130 mmHg | >50 mmHg | <130% | Each 10 mmHg increase in AP | Each 10 % increase in Alx |
Risk of Cardiovascular Events | 3x increased risk of cardiovascular events* |
2-3x increased risk of cardiovascular events* |
2-3x increased risk of cardiovascular events*> |
30% Increase risk of cardiovascular events* |
35-40% Increase risk of cardiovascular events* |
*Cardiovascular events are defined as a myocardial infarction, coronary revascularization, stroke, heart failure, or cardiovascular mortality.
A 4-mmHg reduction in central pressure can lower cardiovascular risk by 20%. Reductions in arterial stiffness have been shown with ACE-inhibitors, calcium channel blockers, statins, PCSK9 inhibitors, and SGLT2 inhibitors.
By tracking these biomarkers, the Pulse helps detect hidden risks, optimize heart health, and empower better cardiovascular decisions.
Central blood pressures have been shown to correlate more strongly with vascular disease than do routine peripheral blood pressure measurements.
Cleveland Clinic
The Gold Standard in Arterial Health—Trusted Worldwide
Powered by SphygmoCor®
CONNEQT Pulse is powered by our patented SphygmoCor® technology, the gold standard in arterial health assessment, used by leading cardiovascular researchers, pharmaceutical companies, and healthcare institutions worldwide.
- Used by Mayo Clinic, Cleveland Clinic, Weill Cornell, and top research hospitals.
- Integrated into clinical trials for major pharmaceutical companies.
- Validated by over 2700 peer reviewed research papers on arterial health and cardiovascular risk assessment.
In a study of 1100 patients central pulse pressure was a powerful predictor of major cardiovascular events, while brachial blood pressure was not
Jankowski et al, Hypertension, 2008